Deerfield Mgmt L.P. is 10% at ANTARES PHARMA, INC. (ATRS). They have made 30 open-market trades across 18 companies since 2014, most recently 2024-10-22.
15 open-market purchases totalling $172.1M since 2014, against 15 sales. Across 15 scored buys the stock is down 5.2% at ninety days, and 10.0 points behind the S&P over the same stretch.
15 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 7% | 33% |
| Avg Move | -3.0% | -6.9% | -5.2% |
| Alpha | -2.8% | -9.7% | -10.0% |
| Scored | 15 | 15 | 15 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 93% | 60% | 73% |
| Avg Move | -11.5% | -4.6% | -7.8% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVL | SELL | 2024-10-22 | 2024-10-24 | $97.75 | $97.8M | -1.9% | +2.1% | -13.2% |
| LRMR | BUY | 2024-02-16 | 2024-02-16 | $8.74 | $50.0M | -11.0% | -35.4% | -42.5% |
| NUVL | BUY | 2022-11-03 | 2022-11-07 | $33.50 | $21.8M | -4.2% | -4.6% | -14.0% |
| XLO | BUY | 2021-10-26 | 2021-10-28 | $16.00 | $6.2M | +41.6% | -9.1% | -16.7% |
| FIXX | SELL | 2019-12-23 | 2019-12-23 | $21.83 | $2.9M | -16.4% | -26.5% | -31.0% |
| FIXX | SELL | 2019-12-20 | 2019-12-23 | $21.50 | $454K | -16.4% | -26.5% | -31.0% |
| FIXX | SELL | 2019-12-19 | 2019-12-23 | $21.68 | $274K | -16.4% | -26.5% | -31.0% |
| FIXX | SELL | 2019-12-19 | 2019-12-23 | $21.79 | $3.4M | -16.4% | -26.5% | -31.0% |
| ACRS | SELL | 2019-06-26 | 2019-06-26 | $4.50 | $8K | -18.6% | -39.2% | -56.8% |
| FIXX | BUY | 2019-04-12 | 2019-04-15 | $22.50 | $24.0M | -2.9% | -2.0% | -14.7% |
| KNSA | BUY | 2018-05-29 | 2018-05-31 | $19.03 | $20.5M | +2.0% | -5.2% | +20.4% |
| CBIO | SELL | 2018-03-06 | 2018-03-21 | $30.57 | $4.0M | -8.3% | +1.8% | -10.0% |
| REPH | SELL | 2017-06-07 | 2017-06-09 | $7.06 | $888K | -3.9% | +2.9% | +9.3% |
| IVTY | SELL | 2016-12-12 | 2016-12-14 | $6.22 | $2.3M | -1.6% | +9.8% | +22.8% |
| AXGN | SELL | 2016-07-21 | 2016-07-21 | $6.70 | $1.4M | +1.2% | +35.1% | +34.6% |
| AXGN | SELL | 2016-07-14 | 2016-07-18 | $7.44 | $2.6M | -1.2% | +31.9% | +27.9% |
| ZFGN | BUY | 2016-02-10 | 2016-02-11 | $6.23 | $942K | +1.7% | -5.5% | +1.4% |
| ZFGN | BUY | 2016-02-09 | 2016-02-11 | $6.02 | $1.6M | +1.7% | -5.5% | +1.4% |
| ZFGN | BUY | 2016-02-09 | 2016-02-11 | $5.73 | $653K | +1.7% | -5.5% | +1.4% |
| XNPT | BUY | 2016-01-20 | 2016-01-22 | $4.09 | $1.4M | -2.2% | -15.7% | -4.7% |
| XNPT | BUY | 2016-01-20 | 2016-01-22 | $4.09 | $1.4M | -2.2% | -15.7% | -4.7% |
| ALIM | BUY | 2015-10-07 | 2015-10-09 | $2.43 | $440K | -20.2% | +0.0% | -6.1% |
| ATRS | SELL | 2015-07-06 | 2015-07-08 | $2.08 | $1.7M | -22.0% | -2.5% | -2.5% |
| ATRS | SELL | 2015-06-26 | 2015-07-01 | $2.24 | $796K | -22.0% | -2.5% | -2.5% |
| ATRS | SELL | 2015-06-16 | 2015-06-18 | $2.44 | $1.2M | -22.0% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| FIXX | 1,917,339 | $32.2M |
| RYTM | 291,005 | $25.1M |
| ALIM | 4,202,889 | $23.3M |
| IVTY | 1,807,239 | $13.4M |
| CBIO | 807,257 | $9.5M |
| LRMR | 4,207,982 | $8.4M |
| CASM | 3,200,000 | $7.8M |
| FREQ | 472,860 | $7.1M |
| XLO | 756,472 | $6.6M |
| ZFGN | 365,698 | $4.3M |
| ACRS | 1,072,775 | $3.5M |
| REPH | 1,287,132 | $2.7M |
| STDY | 265,089 | $1.3M |
| EHTH | 1,384,623 | $804K |
| DFHT | 3,360,000 | — |
| Total | $1.6B |
Shares reported on the most recent Form 4, priced at the 2024-10-24 close. 1 holding could not be priced and is excluded from the total.
| Scored | 15 | 15 | 15 |